Pharming submits a Marketing Authorisation Application to the ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LEIDEN, Netherlands, Oct. 11, 2022 /PRNewswire-AsiaNet/ -- -- Application is based on randomized, controlled and long-term extension data for leniolisib as a treatment for APDS, a rare primary immunodeficiency -- This submission follows the grant of accelerated assessment allowing an expedited review ...
Authors: LATEST ASIANET NEWS RELEASES